Pliant Therapeutics (PLRX) Change in Acquisitions & Divestments (2019 - 2026)

Pliant Therapeutics (PLRX) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $60.7 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $60.7 million, down 27.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $315.1 million (down 3.22% YoY), and the FY2025 annual result was $337.9 million, down 4.94% from the prior year.
• Change in Acquisitions & Divestments retreated to $60.7 million in Q1 2026 per PLRX's latest filing, from $86.9 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $152.8 million in Q3 2023 and troughed at $33.8 million in Q3 2022.
• A 5-year average of $81.7 million and a median of $83.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 55.36% in 2022, then surged 352.17% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $56.5 million in 2022, then surged by 58.36% to $89.5 million in 2023, then dropped by 18.76% to $72.7 million in 2024, then grew by 19.48% to $86.9 million in 2025, then sank by 30.11% to $60.7 million in 2026.
• Business Quant data shows PLRX's Change in Acquisitions & Divestments at $60.7 million in Q1 2026, $86.9 million in Q4 2025, and $80.3 million in Q3 2025.